Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
aligos therapeutics
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
bluebird bio
cavion
cephalgia
chronic hepatitis b virus
david goldstein
demodex blepharitis
depression
duchenne muscular dystrophy
dyne therapeutics
epilepsy
essential tremor
eventide asset management
facioscapulohumeral muscular dystrophy
fda
gene therapy
hepatitis b
horowitz group
isoxazolines
jazz pharmaceuticals
joshua brumm
What
biotechs
2
×
ipos
medicines
2
×
ago
central
cns
considering
data
diseases
disorder
drug
drugs
dyne
early
emerged
expected
experimental
eyes
genetic
having
humans
ipo
kept
leads
long
muscle
nervous
praxis
precision
prep
quiet
rare
reach
research
stealth
therapeutics
way
worked
Language
unset
Current search:
biotechs
×
photo
×
medicines
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
